» Articles » PMID: 30798400

Symptom Frequency and Change of Oldest Old Cancer Patients

Overview
Specialties Critical Care
Oncology
Date 2019 Feb 25
PMID 30798400
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The oldest old, described as those aged 85 and older, is a growing cancer population. There are limited studies evaluating the symptoms of the oldest old cancer patient population. Our study aimed to evaluate symptom frequency and clinical symptom change as assessed by the Edmonton Symptom Assessment System (ESAS) of the oldest old (≥ 85) compared to older adult (65-84) and general adult (18-64) outpatient cancer patients on initial consult and follow-up visit.

Methods: Retrospective review of a total of 441 patients, 200 randomly sampled patients in the general and older adult group and 41 consecutive patients in the oldest old group. Chart review was performed for demographic and clinical information including ESAS.

Results: The oldest old group had less advanced tumors and worse performance status and was receiving less cancer therapy. Eighty percent or more of these patients reported fatigue, sleep disturbance, appetite, and drowsiness. They experienced lower frequencies of pain (p < 0.0001), fatigue (p = 0.0338), nausea (p = 0.0151), feeling of well-being (p = 0.0245), sleep disturbance (p = 0.0484), financial distress (p = 0.0002), and spiritual distress (p = 0.0010) compared to the younger groups. Twenty-six to fifty-one percent of the oldest old patients' symptoms improved on the first follow-up visit.

Conclusions: Oldest old cancer patients have high frequencies of multiple symptoms on initial referral. However, these symptom frequencies are lower when compared to younger age groups. Additionally, many of their symptoms improved on first follow-up visit in the palliative care clinic. More research is needed to address the needs of this growing cancer population and focus symptoms that can improve with palliative care intervention.

Citing Articles

Conditional survival and the prognostic value of serum carcinoembryonic antigen level in oldest old with colorectal cancer.

He W, Yang Y, Liu Q, Luo D, Li Q, Li X BMC Gastroenterol. 2024; 24(1):220.

PMID: 38987680 PMC: 11234783. DOI: 10.1186/s12876-024-03318-4.


[Prevalence and clinical characteristics of pain in patients with advanced chronic disease].

Ballarin Castany A, Serra Rigol T, Cereceda Ferres M, Serrarols Soldevila M, Oller Pique R, Gomez-Batiste X Aten Primaria. 2023; 55(12):102741.

PMID: 37703806 PMC: 10505975. DOI: 10.1016/j.aprim.2023.102741.


Unmet need for mental health services in indolent lymphoma: age differences over one-year post-diagnosis.

Trevino K, Martin P, Saracino R, Leonard J Leuk Lymphoma. 2021; 62(6):1370-1378.

PMID: 34082646 PMC: 8188610. DOI: 10.1080/10428194.2021.1872071.


Pain, symptom distress, and pain barriers by age among patients with cancer receiving hospice care: Comparison of baseline data.

Yoon S, Scarton L, Duckworth L, Yao Y, Ezenwa M, Suarez M J Geriatr Oncol. 2021; 12(7):1068-1075.

PMID: 33967022 PMC: 8429256. DOI: 10.1016/j.jgo.2021.04.008.

References
1.
Vigano A, Bruera E, Suarez-Almazor M . Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer. 1998; 83(6):1244-50. View

2.
Seretny M, Currie G, Sena E, Ramnarine S, Grant R, Macleod M . Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014; 155(12):2461-2470. DOI: 10.1016/j.pain.2014.09.020. View

3.
Breitbart W, Rosenfeld B, Roth A, Smith M, Cohen K, Passik S . The Memorial Delirium Assessment Scale. J Pain Symptom Manage. 1997; 13(3):128-37. DOI: 10.1016/s0885-3924(96)00316-8. View

4.
Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K . Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013; 32(6):1143-52. PMC: 4240626. DOI: 10.1377/hlthaff.2012.1263. View

5.
Cohen L, de Moor C, Eisenberg P, Ming E, Hu H . Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer. 2006; 15(5):497-503. DOI: 10.1007/s00520-006-0173-z. View